Copyright Reports & Markets. All rights reserved.

Global Gene Therapy Medicine Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Gene Therapy Medicine Market Size 2016-2026
    • 2.1.2 Gene Therapy Medicine Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Gene Therapy Medicine Segment by Type
    • 2.2.1 Oral
    • 2.2.2 Oral
  • 2.3 Gene Therapy Medicine Market Size by Type
    • 2.3.1 Global Gene Therapy Medicine Market Size CAGR by Type
    • 2.3.2 Global Gene Therapy Medicine Market Size Market Share by Type (2016-2021)
  • 2.4 Gene Therapy Medicine Segment by Application
    • 2.4.1 Cancer
    • 2.4.2 Monogenic
    • 2.4.3 Infectious Disease
    • 2.4.4 Cardiovascular Disease
    • 2.4.5 Other
  • 2.5 Gene Therapy Medicine Market Size by Application
    • 2.5.1 Global Gene Therapy Medicine Market Size CAGR by Application
    • 2.5.2 Global Gene Therapy Medicine Market Size Market Share by Application (2016-2021)

3 Gene Therapy Medicine Market Size by Players

  • 3.1 Gene Therapy Medicine Market Size Market Share by Players
    • 3.1.1 Global Gene Therapy Medicine Revenue by Players (2019-2021E)
    • 3.1.2 Global Gene Therapy Medicine Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Gene Therapy Medicine Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy Medicine by Regions

  • 4.1 Gene Therapy Medicine Market Size by Regions (2016-2021)
  • 4.2 Americas Gene Therapy Medicine Market Size Growth (2016-2021)
  • 4.3 APAC Gene Therapy Medicine Market Size Growth (2016-2021)
  • 4.4 Europe Gene Therapy Medicine Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Gene Therapy Medicine Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Gene Therapy Medicine Market Size by Country (2016-2021)
  • 5.2 Americas Gene Therapy Medicine Market Size by Type (2016-2021)
  • 5.3 Americas Gene Therapy Medicine Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Gene Therapy Medicine Market Size by Region (2016-2021)
  • 6.2 APAC Gene Therapy Medicine Market Size by Type (2016-2021)
  • 6.3 APAC Gene Therapy Medicine Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Gene Therapy Medicine by Country (2016-2021)
  • 7.2 Europe Gene Therapy Medicine Market Size by Type (2016-2021)
  • 7.3 Europe Gene Therapy Medicine Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Gene Therapy Medicine by Region (2016-2021)
  • 8.2 Middle East & Africa Gene Therapy Medicine Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Gene Therapy Medicine Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Gene Therapy Medicine Market Forecast

  • 10.1 Global Gene Therapy Medicine Forecast by Regions (2021-2026)
    • 10.1.1 Global Gene Therapy Medicine Forecast by Regions (2021-2026)
    • 10.1.2 Americas Gene Therapy Medicine Forecast
    • 10.1.3 APAC Gene Therapy Medicine Forecast
    • 10.1.4 Europe Gene Therapy Medicine Forecast
    • 10.1.5 Middle East & Africa Gene Therapy Medicine Forecast
  • 10.2 Americas Gene Therapy Medicine Forecast by Countries (2021-2026)
    • 10.2.1 United States Gene Therapy Medicine Market Forecast
    • 10.2.2 Canada Gene Therapy Medicine Market Forecast
    • 10.2.3 Mexico Gene Therapy Medicine Market Forecast
    • 10.2.4 Brazil Gene Therapy Medicine Market Forecast
  • 10.3 APAC Gene Therapy Medicine Forecast by Region (2021-2026)
    • 10.3.1 China Gene Therapy Medicine Market Forecast
    • 10.3.2 Japan Gene Therapy Medicine Market Forecast
    • 10.3.3 Korea Gene Therapy Medicine Market Forecast
    • 10.3.4 Southeast Asia Gene Therapy Medicine Market Forecast
    • 10.3.5 India Gene Therapy Medicine Market Forecast
    • 10.3.6 Australia Gene Therapy Medicine Market Forecast
  • 10.4 Europe Gene Therapy Medicine Forecast by Country (2021-2026)
    • 10.4.1 Germany Gene Therapy Medicine Market Forecast
    • 10.4.2 France Gene Therapy Medicine Market Forecast
    • 10.4.3 UK Gene Therapy Medicine Market Forecast
    • 10.4.4 Italy Gene Therapy Medicine Market Forecast
    • 10.4.5 Russia Gene Therapy Medicine Market Forecast
  • 10.5 Middle East & Africa Gene Therapy Medicine Forecast by Region (2021-2026)
    • 10.5.1 Egypt Gene Therapy Medicine Market Forecast
    • 10.5.2 South Africa Gene Therapy Medicine Market Forecast
    • 10.5.3 Israel Gene Therapy Medicine Market Forecast
    • 10.5.4 Turkey Gene Therapy Medicine Market Forecast
    • 10.5.5 GCC Countries Gene Therapy Medicine Market Forecast
  • 10.6 Global Gene Therapy Medicine Forecast by Type (2021-2026)
  • 10.7 Global Gene Therapy Medicine Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Bluebird Bio
    • 11.1.1 Bluebird Bio Company Information
    • 11.1.2 Bluebird Bio Gene Therapy Medicine Product Offered
    • 11.1.3 Bluebird Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Bluebird Bio Main Business Overview
    • 11.1.5 Bluebird Bio Latest Developments
  • 11.2 Sangamo
    • 11.2.1 Sangamo Company Information
    • 11.2.2 Sangamo Gene Therapy Medicine Product Offered
    • 11.2.3 Sangamo Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Sangamo Main Business Overview
    • 11.2.5 Sangamo Latest Developments
  • 11.3 Spark Therapeutics
    • 11.3.1 Spark Therapeutics Company Information
    • 11.3.2 Spark Therapeutics Gene Therapy Medicine Product Offered
    • 11.3.3 Spark Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Spark Therapeutics Main Business Overview
    • 11.3.5 Spark Therapeutics Latest Developments
  • 11.4 Dimension Therapeutics
    • 11.4.1 Dimension Therapeutics Company Information
    • 11.4.2 Dimension Therapeutics Gene Therapy Medicine Product Offered
    • 11.4.3 Dimension Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Dimension Therapeutics Main Business Overview
    • 11.4.5 Dimension Therapeutics Latest Developments
  • 11.5 Avalanche Bio
    • 11.5.1 Avalanche Bio Company Information
    • 11.5.2 Avalanche Bio Gene Therapy Medicine Product Offered
    • 11.5.3 Avalanche Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Avalanche Bio Main Business Overview
    • 11.5.5 Avalanche Bio Latest Developments
  • 11.6 Celladon
    • 11.6.1 Celladon Company Information
    • 11.6.2 Celladon Gene Therapy Medicine Product Offered
    • 11.6.3 Celladon Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Celladon Main Business Overview
    • 11.6.5 Celladon Latest Developments
  • 11.7 Vical Inc.
    • 11.7.1 Vical Inc. Company Information
    • 11.7.2 Vical Inc. Gene Therapy Medicine Product Offered
    • 11.7.3 Vical Inc. Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Vical Inc. Main Business Overview
    • 11.7.5 Vical Inc. Latest Developments
  • 11.8 Advantagene
    • 11.8.1 Advantagene Company Information
    • 11.8.2 Advantagene Gene Therapy Medicine Product Offered
    • 11.8.3 Advantagene Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Advantagene Main Business Overview
    • 11.8.5 Advantagene Latest Developments

12 Research Findings and Conclusion

According to this latest study, the 2021 growth of Gene Therapy Medicine will have significant change from previous year. By the most conservative estimates of global Gene Therapy Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Gene Therapy Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Oral
Injection

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Buy now